Cerebral palsy affects approximately 17 million people worldwide, making it the most common cause of physical disability in childhood. Yet for most families and clinicians, management tends to center on symptom control — physiotherapy, antispasticity medications, surgical procedures — with relatively little attention to the biological signals that drive individual variation in outcomes.

Living with DADA2 — Deficiency of Adenosine Deaminase 2 — sits at an uncomfortable intersection: it is rare enough to be consistently misunderstood, yet severe enough to cause strokes in children, vascular damage across decades, and immune collapse that resembles several diseases at once.

Living with Friedreich's ataxia — or supporting someone who does — means navigating a condition where the body's most fundamental energy machinery is under attack. It is not simply about coordination or balance.

If you are reading this, you are probably not looking for reassurance that blueberries are good for the brain. You want something more useful — a way to understand what is actually happening in your own body and why your current efforts may or may not be moving the needle.

Living with mucopolysaccharidosis, or caring for someone who has it, means navigating a condition that looks different depending on which enzyme is missing, how much residual activity remains, and which organs absorb the most damage over time.

Living with multiple sclerosis — or trying to prevent further progression after a recent diagnosis — means navigating an enormous amount of conflicting advice. Rest more. Exercise more. Eat this.

If you are navigating a diagnosis of Neonatal-Onset Multisystem Inflammatory Disease — or if you are still searching for answers behind a persistent pattern of neonatal rash, recurrent fever, joint swelling, and neurological deterioration — you are dealing with one of the rarest and most biologically specific conditions in all of medicine.

Living with neuromyelitis optica spectrum disorder (NMOSD) means navigating a condition that most clinicians rarely see and most people have never heard of. The attacks arrive with brutal speed — sudden vision loss, ascending paralysis, intractable nausea — and they leave damage behind even when treated aggressively.

Niemann-Pick disease is not a single condition. It is a group of inherited lysosomal storage disorders defined by a molecular failure in how the body processes specific fats — primarily sphingomyelin and cholesterol — at the cellular level.

If someone in your family has been told their bones are "too dense" on an X-ray, or a baby has just been diagnosed with osteopetrosis, the explanation you get at a first appointment is usually thin: "it's genetic, we'll run more tests." That sentence is true and almost useless at the same time.

Living with Parkinson's disease — or supporting someone who does — brings a particular kind of uncertainty that most clinical visits do not fully address. The tremors, the rigidity, the gradual erosion of movement confidence: these are real, and they are frustrating.

Living with Prader-Willi syndrome — whether as a parent, caregiver, or the person directly affected — often means navigating a system where explanations feel incomplete and advice feels generic. You hear about growth hormone therapy and caloric restriction.